| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.0031 | 1 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.0033 | 1 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |